# Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

> **NCT01030731** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 12 (actual)

## Conditions studied

- Staphylococcal Skin Infections
- Streptococcal Infections

## Interventions

- **DRUG:** Ceftobiprole

## Key facts

- **NCT ID:** NCT01030731
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01030731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01030731, "Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01030731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*